• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to H-Phe(4-I)-OH (CAS No. 24250-85-9)

H-Phe(4-I)-OH, also known as L-Phenylalanine (4-Iodo) or L-4-Iodo-Phenylalanine, is a synthetic amino acid with the chemical formula C₉H₁₀INO₃. This compound is characterized by its unique iodine substitution on the phenyl ring, which imparts distinct properties and biological activities. The compound is widely studied in the fields of medicinal chemistry, biochemistry, and pharmaceutical research due to its potential applications in drug development and therapeutic interventions.

The chemical structure of H-Phe(4-I)-OH consists of a central α-amino acid backbone with an iodine-substituted phenyl ring. This structural feature makes it a valuable building block in the synthesis of peptides and proteins, particularly those designed to interact with specific biological targets. The iodine substitution can influence the compound's solubility, stability, and reactivity, making it an attractive candidate for various biochemical and pharmacological studies.

In recent years, significant advancements have been made in understanding the biological activities of H-Phe(4-I)-OH. Research has shown that this compound can modulate various cellular processes, including signal transduction pathways and protein-protein interactions. For instance, studies have demonstrated that H-Phe(4-I)-OH can act as a potent inhibitor of certain enzymes involved in signal transduction, such as protein kinases. This property has led to its exploration as a potential therapeutic agent for treating diseases characterized by aberrant signaling pathways, such as cancer and neurodegenerative disorders.

The synthesis of H-Phe(4-I)-OH involves several well-established chemical reactions. One common method involves the iodination of L-phenylalanine using an appropriate iodinating agent, followed by deprotection to yield the final product. The choice of reagents and reaction conditions can significantly impact the yield and purity of the synthesized compound. Advanced synthetic techniques, such as solid-phase peptide synthesis (SPPS), have also been employed to incorporate H-Phe(4-I)-OH into larger peptide sequences with high efficiency and accuracy.

In addition to its potential therapeutic applications, H-Phe(4-I)-OH has been used as a tool in basic research to investigate the structure-function relationships of proteins and peptides. Its unique chemical properties make it an excellent probe for studying protein folding, stability, and dynamics. For example, researchers have utilized H-Phe(4-I)-OH-containing peptides to explore the effects of halogen substitutions on protein-protein interactions and enzyme catalysis.

The safety profile of H-Phe(4-I)-OH is an important consideration in both research and clinical settings. While the compound is generally considered safe for laboratory use under proper handling conditions, it is essential to follow standard safety protocols to minimize any potential risks. Studies have shown that H-Phe(4-I)-OH exhibits low toxicity in vitro and in vivo, making it a suitable candidate for further preclinical and clinical evaluations.

In conclusion, H-Phe(4-I)-OH (CAS No. 24250-85-9) is a versatile synthetic amino acid with promising applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it a valuable tool for investigating various cellular processes and developing novel therapeutic agents. Ongoing research continues to uncover new insights into the properties and potential uses of this compound, contributing to advancements in the field of biomedicine.

• 14173-41-2(H-DL-Phe(4-I)-OH)
• 20846-38-2(2-Amino-3-(3-iodophenyl)propanoic acid)
• 167817-55-2(2-Iodo-l-phenylalanine)
• 20846-39-3(3-Iodo-L-phenylalanine)
• 1241677-87-1((R)-2-Amino-3-(3-iodophenyl)propanoic acid)
• 62561-75-5(H-D-Phe(4-I)-OH)
• 1986-86-3(2-Amino-3-(2-iodophenyl)propanoic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)